West Pharmaceutical Services (WST) Finished Goods (2010 - 2012)

West Pharmaceutical Services has disclosed Finished Goods across 3 years of filings, most recently posting $65.3 million for Q2 2012.

• In Q2 2012, Finished Goods fell 9.18% year-over-year to $65.3 million; the TTM figure through Jun 2012 stood at $65.3 million (down 9.18% YoY), while the FY2011 annual figure was $67.1 million, up 3.07% from the prior year.
• Finished Goods came in at $65.3 million for Q2 2012 at West Pharmaceutical Services, down from $67.1 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $71.9 million in Q2 2011 to a low of $65.1 million in Q4 2010.
• Average Finished Goods over 3 years is $67.7 million, with a median of $67.1 million recorded in 2011.
• Year-over-year, Finished Goods rose 3.07% in 2011 and decreased 9.18% in 2012.
• Over 3 years, Finished Goods stood at $65.1 million in 2010, then climbed by 3.07% to $67.1 million in 2011, then decreased by 2.68% to $65.3 million in 2012.
• Per Business Quant data, the three most recent Finished Goods figures were $65.3 million in Q2 2012, $67.1 million in Q4 2011, and $68.9 million in Q3 2011.